nodes	percent_of_prediction	percent_of_DWPC	metapath
Pitavastatin—ALB—systemic lupus erythematosus	0.175	1	CbGaD
Pitavastatin—SLC10A1—Cyclosporine—systemic lupus erythematosus	0.0827	0.123	CbGbCtD
Pitavastatin—SLCO1B3—Mycophenolate mofetil—systemic lupus erythematosus	0.0539	0.0798	CbGbCtD
Pitavastatin—UGT2B7—Mycophenolate mofetil—systemic lupus erythematosus	0.0525	0.0777	CbGbCtD
Pitavastatin—ABCG2—Leflunomide—systemic lupus erythematosus	0.0404	0.0598	CbGbCtD
Pitavastatin—SLCO1B1—Mycophenolate mofetil—systemic lupus erythematosus	0.0314	0.0465	CbGbCtD
Pitavastatin—ABCC2—Mycophenolate mofetil—systemic lupus erythematosus	0.0276	0.0409	CbGbCtD
Pitavastatin—ABCG2—Mycophenolate mofetil—systemic lupus erythematosus	0.0249	0.0369	CbGbCtD
Pitavastatin—SLCO1B1—Cyclosporine—systemic lupus erythematosus	0.0238	0.0352	CbGbCtD
Pitavastatin—SLCO1B3—Methotrexate—systemic lupus erythematosus	0.0216	0.032	CbGbCtD
Pitavastatin—ABCC2—Cyclosporine—systemic lupus erythematosus	0.0209	0.031	CbGbCtD
Pitavastatin—ABCG2—Hydrocortisone—systemic lupus erythematosus	0.02	0.0296	CbGbCtD
Pitavastatin—ABCG2—Cyclosporine—systemic lupus erythematosus	0.0189	0.028	CbGbCtD
Pitavastatin—ALB—Mycophenolate mofetil—systemic lupus erythematosus	0.0172	0.0255	CbGbCtD
Pitavastatin—CYP2C8—Dapsone—systemic lupus erythematosus	0.0153	0.0227	CbGbCtD
Pitavastatin—CYP2C9—Leflunomide—systemic lupus erythematosus	0.015	0.0222	CbGbCtD
Pitavastatin—ABCC2—Dexamethasone—systemic lupus erythematosus	0.0138	0.0204	CbGbCtD
Pitavastatin—ALB—Prednisone—systemic lupus erythematosus	0.0137	0.0204	CbGbCtD
Pitavastatin—CYP2C8—Mycophenolate mofetil—systemic lupus erythematosus	0.0133	0.0197	CbGbCtD
Pitavastatin—SLCO1B1—Methotrexate—systemic lupus erythematosus	0.0126	0.0186	CbGbCtD
Pitavastatin—ABCG2—Dexamethasone—systemic lupus erythematosus	0.0124	0.0184	CbGbCtD
Pitavastatin—ABCB1—Methylprednisolone—systemic lupus erythematosus	0.0119	0.0176	CbGbCtD
Pitavastatin—ABCC2—Methotrexate—systemic lupus erythematosus	0.0111	0.0164	CbGbCtD
Pitavastatin—CYP2C9—Dapsone—systemic lupus erythematosus	0.0107	0.0158	CbGbCtD
Pitavastatin—CYP2C8—Hydrocortisone—systemic lupus erythematosus	0.0107	0.0158	CbGbCtD
Pitavastatin—CYP2C8—Cyclosporine—systemic lupus erythematosus	0.0101	0.0149	CbGbCtD
Pitavastatin—ABCG2—Methotrexate—systemic lupus erythematosus	0.01	0.0148	CbGbCtD
Pitavastatin—ABCB1—Mycophenolate mofetil—systemic lupus erythematosus	0.00899	0.0133	CbGbCtD
Pitavastatin—CYP2C9—cardial valve—systemic lupus erythematosus	0.00789	0.2	CbGeAlD
Pitavastatin—ABCB1—Betamethasone—systemic lupus erythematosus	0.00771	0.0114	CbGbCtD
Pitavastatin—ABCB1—Prednisolone—systemic lupus erythematosus	0.00761	0.0113	CbGbCtD
Pitavastatin—ABCB1—Hydrocortisone—systemic lupus erythematosus	0.00722	0.0107	CbGbCtD
Pitavastatin—ABCB1—Prednisone—systemic lupus erythematosus	0.00719	0.0106	CbGbCtD
Pitavastatin—CYP2C9—Cyclosporine—systemic lupus erythematosus	0.00702	0.0104	CbGbCtD
Pitavastatin—ALB—Methotrexate—systemic lupus erythematosus	0.00689	0.0102	CbGbCtD
Pitavastatin—ABCB1—Cyclosporine—systemic lupus erythematosus	0.00681	0.0101	CbGbCtD
Pitavastatin—CYP2C8—Dexamethasone—systemic lupus erythematosus	0.00663	0.00982	CbGbCtD
Pitavastatin—CYP2C9—Dexamethasone—systemic lupus erythematosus	0.00462	0.00685	CbGbCtD
Pitavastatin—ABCB1—Dexamethasone—systemic lupus erythematosus	0.00449	0.00665	CbGbCtD
Pitavastatin—ABCB1—Methotrexate—systemic lupus erythematosus	0.00361	0.00534	CbGbCtD
Pitavastatin—HMGCR—blood plasma—systemic lupus erythematosus	0.00184	0.0465	CbGeAlD
Pitavastatin—SLCO1B1—blood plasma—systemic lupus erythematosus	0.00176	0.0445	CbGeAlD
Pitavastatin—CYP2C9—urine—systemic lupus erythematosus	0.0017	0.0431	CbGeAlD
Pitavastatin—SLC10A1—kidney—systemic lupus erythematosus	0.0012	0.0304	CbGeAlD
Pitavastatin—UGT2B7—kidney—systemic lupus erythematosus	0.00113	0.0285	CbGeAlD
Pitavastatin—CYP2C8—blood plasma—systemic lupus erythematosus	0.001	0.0253	CbGeAlD
Pitavastatin—HMGCR—connective tissue—systemic lupus erythematosus	0.000978	0.0247	CbGeAlD
Pitavastatin—SLCO1B3—lung—systemic lupus erythematosus	0.000977	0.0247	CbGeAlD
Pitavastatin—HMGCR—nephron tubule—systemic lupus erythematosus	0.000947	0.024	CbGeAlD
Pitavastatin—CYP2C9—blood plasma—systemic lupus erythematosus	0.000889	0.0225	CbGeAlD
Pitavastatin—HMGCR—skin of body—systemic lupus erythematosus	0.000883	0.0223	CbGeAlD
Pitavastatin—HMGCR—kidney—systemic lupus erythematosus	0.000832	0.0211	CbGeAlD
Pitavastatin—HMGCR—cortex of kidney—systemic lupus erythematosus	0.000811	0.0205	CbGeAlD
Pitavastatin—SLCO1B1—kidney—systemic lupus erythematosus	0.000797	0.0202	CbGeAlD
Pitavastatin—SLC10A1—nervous system—systemic lupus erythematosus	0.000789	0.02	CbGeAlD
Pitavastatin—SLC10A1—central nervous system—systemic lupus erythematosus	0.00076	0.0192	CbGeAlD
Pitavastatin—HMGCR—lymphoid tissue—systemic lupus erythematosus	0.000715	0.0181	CbGeAlD
Pitavastatin—SLCO2B1—kidney—systemic lupus erythematosus	0.000705	0.0178	CbGeAlD
Pitavastatin—ABCC2—nephron tubule—systemic lupus erythematosus	0.000688	0.0174	CbGeAlD
Pitavastatin—HMGCR—tendon—systemic lupus erythematosus	0.000672	0.017	CbGeAlD
Pitavastatin—HMGCR—bone marrow—systemic lupus erythematosus	0.000651	0.0165	CbGeAlD
Pitavastatin—ABCC2—kidney—systemic lupus erythematosus	0.000604	0.0153	CbGeAlD
Pitavastatin—HMGCR—lung—systemic lupus erythematosus	0.00059	0.0149	CbGeAlD
Pitavastatin—ABCC2—cortex of kidney—systemic lupus erythematosus	0.000589	0.0149	CbGeAlD
Pitavastatin—ORM1—bone marrow—systemic lupus erythematosus	0.000575	0.0146	CbGeAlD
Pitavastatin—SLCO2B1—tendon—systemic lupus erythematosus	0.000569	0.0144	CbGeAlD
Pitavastatin—HMGCR—nervous system—systemic lupus erythematosus	0.000546	0.0138	CbGeAlD
Pitavastatin—HMGCR—central nervous system—systemic lupus erythematosus	0.000526	0.0133	CbGeAlD
Pitavastatin—ORM1—lung—systemic lupus erythematosus	0.000521	0.0132	CbGeAlD
Pitavastatin—ABCG2—nephron tubule—systemic lupus erythematosus	0.000502	0.0127	CbGeAlD
Pitavastatin—SLCO2B1—lung—systemic lupus erythematosus	0.0005	0.0126	CbGeAlD
Pitavastatin—ABCC2—tendon—systemic lupus erythematosus	0.000488	0.0123	CbGeAlD
Pitavastatin—ORM1—nervous system—systemic lupus erythematosus	0.000483	0.0122	CbGeAlD
Pitavastatin—ABCB1—blood plasma—systemic lupus erythematosus	0.00048	0.0121	CbGeAlD
Pitavastatin—ORM1—central nervous system—systemic lupus erythematosus	0.000465	0.0118	CbGeAlD
Pitavastatin—SLCO2B1—nervous system—systemic lupus erythematosus	0.000463	0.0117	CbGeAlD
Pitavastatin—CYP2C8—kidney—systemic lupus erythematosus	0.000453	0.0115	CbGeAlD
Pitavastatin—SLCO2B1—central nervous system—systemic lupus erythematosus	0.000445	0.0113	CbGeAlD
Pitavastatin—ABCG2—bone marrow—systemic lupus erythematosus	0.000345	0.00872	CbGeAlD
Pitavastatin—ABCG2—lung—systemic lupus erythematosus	0.000312	0.0079	CbGeAlD
Pitavastatin—Myalgia—Leflunomide—systemic lupus erythematosus	0.000311	0.00345	CcSEcCtD
Pitavastatin—Arthralgia—Leflunomide—systemic lupus erythematosus	0.000311	0.00345	CcSEcCtD
Pitavastatin—Discomfort—Leflunomide—systemic lupus erythematosus	0.000307	0.00341	CcSEcCtD
Pitavastatin—Hepatic failure—Methotrexate—systemic lupus erythematosus	0.000288	0.0032	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Azathioprine—systemic lupus erythematosus	0.000287	0.00319	CcSEcCtD
Pitavastatin—Renal failure acute—Methotrexate—systemic lupus erythematosus	0.00028	0.00311	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Leflunomide—systemic lupus erythematosus	0.000271	0.00302	CcSEcCtD
Pitavastatin—Muscle spasms—Cyclosporine—systemic lupus erythematosus	0.000271	0.00301	CcSEcCtD
Pitavastatin—Insomnia—Leflunomide—systemic lupus erythematosus	0.000269	0.00299	CcSEcCtD
Pitavastatin—Back pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000266	0.00295	CcSEcCtD
Pitavastatin—Muscle spasms—Mycophenolate mofetil—systemic lupus erythematosus	0.000264	0.00294	CcSEcCtD
Pitavastatin—Dyspepsia—Leflunomide—systemic lupus erythematosus	0.000262	0.00291	CcSEcCtD
Pitavastatin—Ill-defined disorder—Cyclosporine—systemic lupus erythematosus	0.000261	0.0029	CcSEcCtD
Pitavastatin—Feeling abnormal—Azathioprine—systemic lupus erythematosus	0.00026	0.00289	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Azathioprine—systemic lupus erythematosus	0.000258	0.00287	CcSEcCtD
Pitavastatin—Fatigue—Leflunomide—systemic lupus erythematosus	0.000257	0.00285	CcSEcCtD
Pitavastatin—Ill-defined disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000255	0.00283	CcSEcCtD
Pitavastatin—Constipation—Leflunomide—systemic lupus erythematosus	0.000255	0.00283	CcSEcCtD
Pitavastatin—Malaise—Cyclosporine—systemic lupus erythematosus	0.000254	0.00282	CcSEcCtD
Pitavastatin—Abdominal pain—Azathioprine—systemic lupus erythematosus	0.000249	0.00277	CcSEcCtD
Pitavastatin—Malaise—Mycophenolate mofetil—systemic lupus erythematosus	0.000248	0.00275	CcSEcCtD
Pitavastatin—ABCB1—nephron tubule—systemic lupus erythematosus	0.000247	0.00626	CbGeAlD
Pitavastatin—Erectile dysfunction—Prednisone—systemic lupus erythematosus	0.000246	0.00274	CcSEcCtD
Pitavastatin—Feeling abnormal—Leflunomide—systemic lupus erythematosus	0.000245	0.00273	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Leflunomide—systemic lupus erythematosus	0.000244	0.00271	CcSEcCtD
Pitavastatin—Myalgia—Cyclosporine—systemic lupus erythematosus	0.00024	0.00266	CcSEcCtD
Pitavastatin—Arthralgia—Cyclosporine—systemic lupus erythematosus	0.00024	0.00266	CcSEcCtD
Pitavastatin—Ill-defined disorder—Prednisolone—systemic lupus erythematosus	0.000238	0.00264	CcSEcCtD
Pitavastatin—Discomfort—Cyclosporine—systemic lupus erythematosus	0.000237	0.00263	CcSEcCtD
Pitavastatin—Urticaria—Leflunomide—systemic lupus erythematosus	0.000237	0.00263	CcSEcCtD
Pitavastatin—Abdominal pain—Leflunomide—systemic lupus erythematosus	0.000235	0.00262	CcSEcCtD
Pitavastatin—Arthralgia—Mycophenolate mofetil—systemic lupus erythematosus	0.000234	0.0026	CcSEcCtD
Pitavastatin—Myalgia—Mycophenolate mofetil—systemic lupus erythematosus	0.000234	0.0026	CcSEcCtD
Pitavastatin—Hypersensitivity—Azathioprine—systemic lupus erythematosus	0.000232	0.00258	CcSEcCtD
Pitavastatin—Ill-defined disorder—Hydrocortisone—systemic lupus erythematosus	0.000232	0.00258	CcSEcCtD
Pitavastatin—Confusional state—Cyclosporine—systemic lupus erythematosus	0.000232	0.00258	CcSEcCtD
Pitavastatin—Malaise—Prednisolone—systemic lupus erythematosus	0.000231	0.00257	CcSEcCtD
Pitavastatin—Discomfort—Mycophenolate mofetil—systemic lupus erythematosus	0.000231	0.00257	CcSEcCtD
Pitavastatin—Back pain—Triamcinolone—systemic lupus erythematosus	0.000228	0.00253	CcSEcCtD
Pitavastatin—Confusional state—Mycophenolate mofetil—systemic lupus erythematosus	0.000226	0.00251	CcSEcCtD
Pitavastatin—Malaise—Hydrocortisone—systemic lupus erythematosus	0.000226	0.00251	CcSEcCtD
Pitavastatin—Hypersensitivity—Leflunomide—systemic lupus erythematosus	0.000219	0.00244	CcSEcCtD
Pitavastatin—Ill-defined disorder—Triamcinolone—systemic lupus erythematosus	0.000219	0.00243	CcSEcCtD
Pitavastatin—Ill-defined disorder—Methylprednisolone—systemic lupus erythematosus	0.000218	0.00242	CcSEcCtD
Pitavastatin—ABCB1—kidney—systemic lupus erythematosus	0.000217	0.0055	CbGeAlD
Pitavastatin—Diarrhoea—Azathioprine—systemic lupus erythematosus	0.000216	0.0024	CcSEcCtD
Pitavastatin—Discomfort—Prednisolone—systemic lupus erythematosus	0.000216	0.0024	CcSEcCtD
Pitavastatin—Abdominal discomfort—Methotrexate—systemic lupus erythematosus	0.000214	0.00238	CcSEcCtD
Pitavastatin—Asthenia—Leflunomide—systemic lupus erythematosus	0.000214	0.00237	CcSEcCtD
Pitavastatin—Myalgia—Hydrocortisone—systemic lupus erythematosus	0.000213	0.00237	CcSEcCtD
Pitavastatin—Malaise—Triamcinolone—systemic lupus erythematosus	0.000213	0.00236	CcSEcCtD
Pitavastatin—Malaise—Methylprednisolone—systemic lupus erythematosus	0.000212	0.00236	CcSEcCtD
Pitavastatin—ABCB1—cortex of kidney—systemic lupus erythematosus	0.000212	0.00536	CbGeAlD
Pitavastatin—Pruritus—Leflunomide—systemic lupus erythematosus	0.000211	0.00234	CcSEcCtD
Pitavastatin—Discomfort—Hydrocortisone—systemic lupus erythematosus	0.000211	0.00234	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Cyclosporine—systemic lupus erythematosus	0.000209	0.00233	CcSEcCtD
Pitavastatin—Dizziness—Azathioprine—systemic lupus erythematosus	0.000209	0.00232	CcSEcCtD
Pitavastatin—Insomnia—Cyclosporine—systemic lupus erythematosus	0.000208	0.00231	CcSEcCtD
Pitavastatin—Erectile dysfunction—Methotrexate—systemic lupus erythematosus	0.000206	0.00229	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Mycophenolate mofetil—systemic lupus erythematosus	0.000204	0.00227	CcSEcCtD
Pitavastatin—Diarrhoea—Leflunomide—systemic lupus erythematosus	0.000204	0.00226	CcSEcCtD
Pitavastatin—Insomnia—Mycophenolate mofetil—systemic lupus erythematosus	0.000203	0.00225	CcSEcCtD
Pitavastatin—Dyspepsia—Cyclosporine—systemic lupus erythematosus	0.000202	0.00225	CcSEcCtD
Pitavastatin—Myalgia—Triamcinolone—systemic lupus erythematosus	0.000201	0.00223	CcSEcCtD
Pitavastatin—Myalgia—Methylprednisolone—systemic lupus erythematosus	0.0002	0.00222	CcSEcCtD
Pitavastatin—Arthralgia—Methylprednisolone—systemic lupus erythematosus	0.0002	0.00222	CcSEcCtD
Pitavastatin—Rash—Azathioprine—systemic lupus erythematosus	0.000199	0.00221	CcSEcCtD
Pitavastatin—Dermatitis—Azathioprine—systemic lupus erythematosus	0.000199	0.00221	CcSEcCtD
Pitavastatin—Ill-defined disorder—Betamethasone—systemic lupus erythematosus	0.000198	0.0022	CcSEcCtD
Pitavastatin—Ill-defined disorder—Dexamethasone—systemic lupus erythematosus	0.000198	0.0022	CcSEcCtD
Pitavastatin—Discomfort—Triamcinolone—systemic lupus erythematosus	0.000198	0.0022	CcSEcCtD
Pitavastatin—Fatigue—Cyclosporine—systemic lupus erythematosus	0.000198	0.0022	CcSEcCtD
Pitavastatin—Discomfort—Methylprednisolone—systemic lupus erythematosus	0.000198	0.0022	CcSEcCtD
Pitavastatin—Headache—Azathioprine—systemic lupus erythematosus	0.000198	0.0022	CcSEcCtD
Pitavastatin—Dyspepsia—Mycophenolate mofetil—systemic lupus erythematosus	0.000197	0.00219	CcSEcCtD
Pitavastatin—Dizziness—Leflunomide—systemic lupus erythematosus	0.000197	0.00219	CcSEcCtD
Pitavastatin—Constipation—Cyclosporine—systemic lupus erythematosus	0.000197	0.00218	CcSEcCtD
Pitavastatin—Confusional state—Methylprednisolone—systemic lupus erythematosus	0.000194	0.00215	CcSEcCtD
Pitavastatin—Malaise—Betamethasone—systemic lupus erythematosus	0.000193	0.00214	CcSEcCtD
Pitavastatin—Malaise—Dexamethasone—systemic lupus erythematosus	0.000193	0.00214	CcSEcCtD
Pitavastatin—Constipation—Mycophenolate mofetil—systemic lupus erythematosus	0.000192	0.00213	CcSEcCtD
Pitavastatin—Feeling abnormal—Cyclosporine—systemic lupus erythematosus	0.000189	0.0021	CcSEcCtD
Pitavastatin—Insomnia—Prednisolone—systemic lupus erythematosus	0.000189	0.0021	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Cyclosporine—systemic lupus erythematosus	0.000188	0.00209	CcSEcCtD
Pitavastatin—Rash—Leflunomide—systemic lupus erythematosus	0.000188	0.00209	CcSEcCtD
Pitavastatin—Dermatitis—Leflunomide—systemic lupus erythematosus	0.000188	0.00208	CcSEcCtD
Pitavastatin—Nausea—Azathioprine—systemic lupus erythematosus	0.000187	0.00208	CcSEcCtD
Pitavastatin—ABCB1—lymphoid tissue—systemic lupus erythematosus	0.000187	0.00472	CbGeAlD
Pitavastatin—Headache—Leflunomide—systemic lupus erythematosus	0.000187	0.00207	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Hydrocortisone—systemic lupus erythematosus	0.000186	0.00207	CcSEcCtD
Pitavastatin—Feeling abnormal—Mycophenolate mofetil—systemic lupus erythematosus	0.000185	0.00205	CcSEcCtD
Pitavastatin—Insomnia—Hydrocortisone—systemic lupus erythematosus	0.000185	0.00205	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000183	0.00204	CcSEcCtD
Pitavastatin—Urticaria—Cyclosporine—systemic lupus erythematosus	0.000183	0.00203	CcSEcCtD
Pitavastatin—Myalgia—Betamethasone—systemic lupus erythematosus	0.000182	0.00202	CcSEcCtD
Pitavastatin—Myalgia—Dexamethasone—systemic lupus erythematosus	0.000182	0.00202	CcSEcCtD
Pitavastatin—Abdominal pain—Cyclosporine—systemic lupus erythematosus	0.000182	0.00202	CcSEcCtD
Pitavastatin—Discomfort—Dexamethasone—systemic lupus erythematosus	0.00018	0.002	CcSEcCtD
Pitavastatin—Discomfort—Betamethasone—systemic lupus erythematosus	0.00018	0.002	CcSEcCtD
Pitavastatin—Dyspepsia—Hydrocortisone—systemic lupus erythematosus	0.00018	0.002	CcSEcCtD
Pitavastatin—Hepatitis—Methotrexate—systemic lupus erythematosus	0.000179	0.00199	CcSEcCtD
Pitavastatin—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	0.000178	0.00198	CcSEcCtD
Pitavastatin—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000177	0.00197	CcSEcCtD
Pitavastatin—Nausea—Leflunomide—systemic lupus erythematosus	0.000177	0.00197	CcSEcCtD
Pitavastatin—Fatigue—Hydrocortisone—systemic lupus erythematosus	0.000176	0.00196	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	0.000175	0.00195	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	0.000175	0.00194	CcSEcCtD
Pitavastatin—Insomnia—Triamcinolone—systemic lupus erythematosus	0.000174	0.00193	CcSEcCtD
Pitavastatin—Insomnia—Methylprednisolone—systemic lupus erythematosus	0.000174	0.00193	CcSEcCtD
Pitavastatin—Ill-defined disorder—Prednisone—systemic lupus erythematosus	0.000173	0.00192	CcSEcCtD
Pitavastatin—Feeling abnormal—Prednisolone—systemic lupus erythematosus	0.000172	0.00192	CcSEcCtD
Pitavastatin—ABCB1—bone marrow—systemic lupus erythematosus	0.00017	0.0043	CbGeAlD
Pitavastatin—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	0.000169	0.00188	CcSEcCtD
Pitavastatin—Dyspepsia—Triamcinolone—systemic lupus erythematosus	0.000169	0.00188	CcSEcCtD
Pitavastatin—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	0.000169	0.00188	CcSEcCtD
Pitavastatin—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	0.000168	0.00187	CcSEcCtD
Pitavastatin—Malaise—Prednisone—systemic lupus erythematosus	0.000168	0.00187	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	0.000167	0.00186	CcSEcCtD
Pitavastatin—Urticaria—Prednisolone—systemic lupus erythematosus	0.000166	0.00185	CcSEcCtD
Pitavastatin—Fatigue—Triamcinolone—systemic lupus erythematosus	0.000166	0.00184	CcSEcCtD
Pitavastatin—Fatigue—Methylprednisolone—systemic lupus erythematosus	0.000165	0.00184	CcSEcCtD
Pitavastatin—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	0.000165	0.00184	CcSEcCtD
Pitavastatin—Asthenia—Cyclosporine—systemic lupus erythematosus	0.000165	0.00183	CcSEcCtD
Pitavastatin—Pruritus—Cyclosporine—systemic lupus erythematosus	0.000163	0.00181	CcSEcCtD
Pitavastatin—Urticaria—Hydrocortisone—systemic lupus erythematosus	0.000162	0.0018	CcSEcCtD
Pitavastatin—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	0.000161	0.00179	CcSEcCtD
Pitavastatin—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000161	0.00179	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	0.000159	0.00177	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	0.000159	0.00177	CcSEcCtD
Pitavastatin—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	0.000159	0.00176	CcSEcCtD
Pitavastatin—Arthralgia—Prednisone—systemic lupus erythematosus	0.000159	0.00176	CcSEcCtD
Pitavastatin—Myalgia—Prednisone—systemic lupus erythematosus	0.000159	0.00176	CcSEcCtD
Pitavastatin—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	0.000158	0.00176	CcSEcCtD
Pitavastatin—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	0.000158	0.00176	CcSEcCtD
Pitavastatin—Insomnia—Dexamethasone—systemic lupus erythematosus	0.000158	0.00175	CcSEcCtD
Pitavastatin—Insomnia—Betamethasone—systemic lupus erythematosus	0.000158	0.00175	CcSEcCtD
Pitavastatin—Diarrhoea—Cyclosporine—systemic lupus erythematosus	0.000157	0.00175	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	0.000157	0.00174	CcSEcCtD
Pitavastatin—Discomfort—Prednisone—systemic lupus erythematosus	0.000157	0.00174	CcSEcCtD
Pitavastatin—Hypersensitivity—Prednisolone—systemic lupus erythematosus	0.000154	0.00171	CcSEcCtD
Pitavastatin—ABCB1—lung—systemic lupus erythematosus	0.000154	0.0039	CbGeAlD
Pitavastatin—Dyspepsia—Betamethasone—systemic lupus erythematosus	0.000154	0.00171	CcSEcCtD
Pitavastatin—Dyspepsia—Dexamethasone—systemic lupus erythematosus	0.000154	0.00171	CcSEcCtD
Pitavastatin—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	0.000153	0.0017	CcSEcCtD
Pitavastatin—Urticaria—Triamcinolone—systemic lupus erythematosus	0.000153	0.0017	CcSEcCtD
Pitavastatin—Urticaria—Methylprednisolone—systemic lupus erythematosus	0.000152	0.00169	CcSEcCtD
Pitavastatin—Dizziness—Cyclosporine—systemic lupus erythematosus	0.000152	0.00169	CcSEcCtD
Pitavastatin—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	0.000152	0.00169	CcSEcCtD
Pitavastatin—Back pain—Methotrexate—systemic lupus erythematosus	0.000151	0.00167	CcSEcCtD
Pitavastatin—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	0.00015	0.00167	CcSEcCtD
Pitavastatin—Fatigue—Betamethasone—systemic lupus erythematosus	0.00015	0.00167	CcSEcCtD
Pitavastatin—Fatigue—Dexamethasone—systemic lupus erythematosus	0.00015	0.00167	CcSEcCtD
Pitavastatin—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.000148	0.00165	CcSEcCtD
Pitavastatin—Asthenia—Hydrocortisone—systemic lupus erythematosus	0.000147	0.00163	CcSEcCtD
Pitavastatin—Rash—Cyclosporine—systemic lupus erythematosus	0.000145	0.00161	CcSEcCtD
Pitavastatin—Dermatitis—Cyclosporine—systemic lupus erythematosus	0.000145	0.00161	CcSEcCtD
Pitavastatin—Pruritus—Hydrocortisone—systemic lupus erythematosus	0.000145	0.00161	CcSEcCtD
Pitavastatin—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	0.000144	0.0016	CcSEcCtD
Pitavastatin—Headache—Cyclosporine—systemic lupus erythematosus	0.000144	0.0016	CcSEcCtD
Pitavastatin—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	0.000144	0.0016	CcSEcCtD
Pitavastatin—Feeling abnormal—Betamethasone—systemic lupus erythematosus	0.000144	0.0016	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	0.000143	0.00159	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	0.000143	0.00159	CcSEcCtD
Pitavastatin—ABCB1—nervous system—systemic lupus erythematosus	0.000143	0.00361	CbGeAlD
Pitavastatin—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	0.000142	0.00157	CcSEcCtD
Pitavastatin—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	0.000141	0.00157	CcSEcCtD
Pitavastatin—Rash—Mycophenolate mofetil—systemic lupus erythematosus	0.000141	0.00157	CcSEcCtD
Pitavastatin—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.000141	0.00157	CcSEcCtD
Pitavastatin—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.00014	0.00156	CcSEcCtD
Pitavastatin—Malaise—Methotrexate—systemic lupus erythematosus	0.00014	0.00156	CcSEcCtD
Pitavastatin—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	0.00014	0.00155	CcSEcCtD
Pitavastatin—Urticaria—Betamethasone—systemic lupus erythematosus	0.000139	0.00154	CcSEcCtD
Pitavastatin—Urticaria—Dexamethasone—systemic lupus erythematosus	0.000139	0.00154	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	0.000138	0.00154	CcSEcCtD
Pitavastatin—Dizziness—Prednisolone—systemic lupus erythematosus	0.000138	0.00154	CcSEcCtD
Pitavastatin—Asthenia—Triamcinolone—systemic lupus erythematosus	0.000138	0.00153	CcSEcCtD
Pitavastatin—Abdominal pain—Betamethasone—systemic lupus erythematosus	0.000138	0.00153	CcSEcCtD
Pitavastatin—Abdominal pain—Dexamethasone—systemic lupus erythematosus	0.000138	0.00153	CcSEcCtD
Pitavastatin—Asthenia—Methylprednisolone—systemic lupus erythematosus	0.000138	0.00153	CcSEcCtD
Pitavastatin—Insomnia—Prednisone—systemic lupus erythematosus	0.000137	0.00153	CcSEcCtD
Pitavastatin—ABCB1—central nervous system—systemic lupus erythematosus	0.000137	0.00347	CbGeAlD
Pitavastatin—Nausea—Cyclosporine—systemic lupus erythematosus	0.000137	0.00152	CcSEcCtD
Pitavastatin—Pruritus—Triamcinolone—systemic lupus erythematosus	0.000136	0.00151	CcSEcCtD
Pitavastatin—Pruritus—Methylprednisolone—systemic lupus erythematosus	0.000136	0.00151	CcSEcCtD
Pitavastatin—Dizziness—Hydrocortisone—systemic lupus erythematosus	0.000135	0.0015	CcSEcCtD
Pitavastatin—Dyspepsia—Prednisone—systemic lupus erythematosus	0.000134	0.00149	CcSEcCtD
Pitavastatin—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.000133	0.00148	CcSEcCtD
Pitavastatin—Arthralgia—Methotrexate—systemic lupus erythematosus	0.000132	0.00147	CcSEcCtD
Pitavastatin—Myalgia—Methotrexate—systemic lupus erythematosus	0.000132	0.00147	CcSEcCtD
Pitavastatin—Rash—Prednisolone—systemic lupus erythematosus	0.000132	0.00147	CcSEcCtD
Pitavastatin—Dermatitis—Prednisolone—systemic lupus erythematosus	0.000132	0.00146	CcSEcCtD
Pitavastatin—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	0.000131	0.00146	CcSEcCtD
Pitavastatin—Fatigue—Prednisone—systemic lupus erythematosus	0.000131	0.00146	CcSEcCtD
Pitavastatin—Headache—Prednisolone—systemic lupus erythematosus	0.000131	0.00146	CcSEcCtD
Pitavastatin—Discomfort—Methotrexate—systemic lupus erythematosus	0.000131	0.00145	CcSEcCtD
Pitavastatin—Constipation—Prednisone—systemic lupus erythematosus	0.00013	0.00144	CcSEcCtD
Pitavastatin—Rash—Hydrocortisone—systemic lupus erythematosus	0.000129	0.00143	CcSEcCtD
Pitavastatin—Dermatitis—Hydrocortisone—systemic lupus erythematosus	0.000129	0.00143	CcSEcCtD
Pitavastatin—Confusional state—Methotrexate—systemic lupus erythematosus	0.000128	0.00142	CcSEcCtD
Pitavastatin—Headache—Hydrocortisone—systemic lupus erythematosus	0.000128	0.00142	CcSEcCtD
Pitavastatin—Dizziness—Triamcinolone—systemic lupus erythematosus	0.000127	0.00141	CcSEcCtD
Pitavastatin—Dizziness—Methylprednisolone—systemic lupus erythematosus	0.000127	0.00141	CcSEcCtD
Pitavastatin—Feeling abnormal—Prednisone—systemic lupus erythematosus	0.000125	0.00139	CcSEcCtD
Pitavastatin—Asthenia—Betamethasone—systemic lupus erythematosus	0.000125	0.00139	CcSEcCtD
Pitavastatin—Asthenia—Dexamethasone—systemic lupus erythematosus	0.000125	0.00139	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	0.000124	0.00138	CcSEcCtD
Pitavastatin—Nausea—Prednisolone—systemic lupus erythematosus	0.000124	0.00138	CcSEcCtD
Pitavastatin—Pruritus—Betamethasone—systemic lupus erythematosus	0.000123	0.00137	CcSEcCtD
Pitavastatin—Pruritus—Dexamethasone—systemic lupus erythematosus	0.000123	0.00137	CcSEcCtD
Pitavastatin—Nausea—Hydrocortisone—systemic lupus erythematosus	0.000121	0.00135	CcSEcCtD
Pitavastatin—Rash—Triamcinolone—systemic lupus erythematosus	0.000121	0.00135	CcSEcCtD
Pitavastatin—Dermatitis—Triamcinolone—systemic lupus erythematosus	0.000121	0.00135	CcSEcCtD
Pitavastatin—Rash—Methylprednisolone—systemic lupus erythematosus	0.000121	0.00134	CcSEcCtD
Pitavastatin—Dermatitis—Methylprednisolone—systemic lupus erythematosus	0.000121	0.00134	CcSEcCtD
Pitavastatin—Urticaria—Prednisone—systemic lupus erythematosus	0.000121	0.00134	CcSEcCtD
Pitavastatin—Headache—Triamcinolone—systemic lupus erythematosus	0.00012	0.00134	CcSEcCtD
Pitavastatin—Headache—Methylprednisolone—systemic lupus erythematosus	0.00012	0.00134	CcSEcCtD
Pitavastatin—Abdominal pain—Prednisone—systemic lupus erythematosus	0.00012	0.00134	CcSEcCtD
Pitavastatin—Diarrhoea—Dexamethasone—systemic lupus erythematosus	0.000119	0.00133	CcSEcCtD
Pitavastatin—Diarrhoea—Betamethasone—systemic lupus erythematosus	0.000119	0.00133	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	0.000116	0.00129	CcSEcCtD
Pitavastatin—Dizziness—Dexamethasone—systemic lupus erythematosus	0.000115	0.00128	CcSEcCtD
Pitavastatin—Dizziness—Betamethasone—systemic lupus erythematosus	0.000115	0.00128	CcSEcCtD
Pitavastatin—Insomnia—Methotrexate—systemic lupus erythematosus	0.000115	0.00128	CcSEcCtD
Pitavastatin—Nausea—Triamcinolone—systemic lupus erythematosus	0.000114	0.00127	CcSEcCtD
Pitavastatin—Nausea—Methylprednisolone—systemic lupus erythematosus	0.000114	0.00127	CcSEcCtD
Pitavastatin—Hypersensitivity—Prednisone—systemic lupus erythematosus	0.000112	0.00124	CcSEcCtD
Pitavastatin—Dyspepsia—Methotrexate—systemic lupus erythematosus	0.000112	0.00124	CcSEcCtD
Pitavastatin—Rash—Dexamethasone—systemic lupus erythematosus	0.00011	0.00122	CcSEcCtD
Pitavastatin—Rash—Betamethasone—systemic lupus erythematosus	0.00011	0.00122	CcSEcCtD
Pitavastatin—Dermatitis—Dexamethasone—systemic lupus erythematosus	0.00011	0.00122	CcSEcCtD
Pitavastatin—Dermatitis—Betamethasone—systemic lupus erythematosus	0.00011	0.00122	CcSEcCtD
Pitavastatin—Fatigue—Methotrexate—systemic lupus erythematosus	0.00011	0.00122	CcSEcCtD
Pitavastatin—Headache—Dexamethasone—systemic lupus erythematosus	0.000109	0.00121	CcSEcCtD
Pitavastatin—Headache—Betamethasone—systemic lupus erythematosus	0.000109	0.00121	CcSEcCtD
Pitavastatin—Asthenia—Prednisone—systemic lupus erythematosus	0.000109	0.00121	CcSEcCtD
Pitavastatin—Pruritus—Prednisone—systemic lupus erythematosus	0.000108	0.00119	CcSEcCtD
Pitavastatin—Feeling abnormal—Methotrexate—systemic lupus erythematosus	0.000105	0.00116	CcSEcCtD
Pitavastatin—Diarrhoea—Prednisone—systemic lupus erythematosus	0.000104	0.00116	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	0.000104	0.00115	CcSEcCtD
Pitavastatin—Nausea—Dexamethasone—systemic lupus erythematosus	0.000104	0.00115	CcSEcCtD
Pitavastatin—Nausea—Betamethasone—systemic lupus erythematosus	0.000104	0.00115	CcSEcCtD
Pitavastatin—Urticaria—Methotrexate—systemic lupus erythematosus	0.000101	0.00112	CcSEcCtD
Pitavastatin—Dizziness—Prednisone—systemic lupus erythematosus	0.000101	0.00112	CcSEcCtD
Pitavastatin—Abdominal pain—Methotrexate—systemic lupus erythematosus	0.0001	0.00112	CcSEcCtD
Pitavastatin—Rash—Prednisone—systemic lupus erythematosus	9.58e-05	0.00106	CcSEcCtD
Pitavastatin—Dermatitis—Prednisone—systemic lupus erythematosus	9.57e-05	0.00106	CcSEcCtD
Pitavastatin—Headache—Prednisone—systemic lupus erythematosus	9.52e-05	0.00106	CcSEcCtD
Pitavastatin—Hypersensitivity—Methotrexate—systemic lupus erythematosus	9.36e-05	0.00104	CcSEcCtD
Pitavastatin—Asthenia—Methotrexate—systemic lupus erythematosus	9.11e-05	0.00101	CcSEcCtD
Pitavastatin—Nausea—Prednisone—systemic lupus erythematosus	9.03e-05	0.001	CcSEcCtD
Pitavastatin—Pruritus—Methotrexate—systemic lupus erythematosus	8.99e-05	0.000999	CcSEcCtD
Pitavastatin—Diarrhoea—Methotrexate—systemic lupus erythematosus	8.69e-05	0.000966	CcSEcCtD
Pitavastatin—Dizziness—Methotrexate—systemic lupus erythematosus	8.4e-05	0.000933	CcSEcCtD
Pitavastatin—Rash—Methotrexate—systemic lupus erythematosus	8.01e-05	0.00089	CcSEcCtD
Pitavastatin—Dermatitis—Methotrexate—systemic lupus erythematosus	8e-05	0.000889	CcSEcCtD
Pitavastatin—Headache—Methotrexate—systemic lupus erythematosus	7.96e-05	0.000884	CcSEcCtD
Pitavastatin—Nausea—Methotrexate—systemic lupus erythematosus	7.54e-05	0.000838	CcSEcCtD
Pitavastatin—Rosuvastatin—ALB—systemic lupus erythematosus	6.26e-05	1	CrCbGaD
Pitavastatin—CYP2C8—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	6.01e-05	0.003	CbGpPWpGaD
Pitavastatin—ABCG2—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	5.98e-05	0.00299	CbGpPWpGaD
Pitavastatin—ABCG2—HIF-2-alpha transcription factor network—VEGFA—systemic lupus erythematosus	5.97e-05	0.00298	CbGpPWpGaD
Pitavastatin—ABCB1—HIF-1-alpha transcription factor network—CXCL12—systemic lupus erythematosus	5.64e-05	0.00282	CbGpPWpGaD
Pitavastatin—ABCC2—NRF2 pathway—RXRA—systemic lupus erythematosus	5.47e-05	0.00273	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—IL17A—systemic lupus erythematosus	5.44e-05	0.00272	CbGpPWpGaD
Pitavastatin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—systemic lupus erythematosus	5.36e-05	0.00267	CbGpPWpGaD
Pitavastatin—HMGCR—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—systemic lupus erythematosus	5.31e-05	0.00265	CbGpPWpGaD
Pitavastatin—ALB—FOXA2 and FOXA3 transcription factor networks—F2—systemic lupus erythematosus	5.23e-05	0.00261	CbGpPWpGaD
Pitavastatin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	5.21e-05	0.0026	CbGpPWpGaD
Pitavastatin—HMGCR—PPARA activates gene expression—EP300—systemic lupus erythematosus	5.15e-05	0.00257	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—IL12B—systemic lupus erythematosus	5.06e-05	0.00253	CbGpPWpGaD
Pitavastatin—HMGCR—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—systemic lupus erythematosus	5.04e-05	0.00252	CbGpPWpGaD
Pitavastatin—ALB—Vitamin B12 Metabolism—CRP—systemic lupus erythematosus	5.04e-05	0.00252	CbGpPWpGaD
Pitavastatin—CYP2C9—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	4.89e-05	0.00244	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—CXCL12—systemic lupus erythematosus	4.88e-05	0.00244	CbGpPWpGaD
Pitavastatin—CYP2C8—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	4.87e-05	0.00243	CbGpPWpGaD
Pitavastatin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	4.86e-05	0.00243	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—CD40—systemic lupus erythematosus	4.83e-05	0.00241	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—CTLA4—systemic lupus erythematosus	4.76e-05	0.00238	CbGpPWpGaD
Pitavastatin—ALB—Folate Metabolism—IL4—systemic lupus erythematosus	4.74e-05	0.00237	CbGpPWpGaD
Pitavastatin—ALB—Vitamin B12 Metabolism—F2—systemic lupus erythematosus	4.65e-05	0.00232	CbGpPWpGaD
Pitavastatin—CYP2C8—Biological oxidations—NAT2—systemic lupus erythematosus	4.62e-05	0.0023	CbGpPWpGaD
Pitavastatin—CYP2C8—Metapathway biotransformation—NAT2—systemic lupus erythematosus	4.55e-05	0.00227	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—HLA-DQA1—systemic lupus erythematosus	4.19e-05	0.00209	CbGpPWpGaD
Pitavastatin—ALB—Vitamin B12 Metabolism—CCL2—systemic lupus erythematosus	4.15e-05	0.00207	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	4.11e-05	0.00205	CbGpPWpGaD
Pitavastatin—ALB—Folate Metabolism—CRP—systemic lupus erythematosus	4.1e-05	0.00205	CbGpPWpGaD
Pitavastatin—HMGCR—Integrated Breast Cancer Pathway—EP300—systemic lupus erythematosus	4e-05	0.002	CbGpPWpGaD
Pitavastatin—CYP2C9—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	3.96e-05	0.00198	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—HLA-DQB1—systemic lupus erythematosus	3.92e-05	0.00196	CbGpPWpGaD
Pitavastatin—HMGCR—Integrated Breast Cancer Pathway—VEGFA—systemic lupus erythematosus	3.79e-05	0.00189	CbGpPWpGaD
Pitavastatin—ALB—Folate Metabolism—F2—systemic lupus erythematosus	3.78e-05	0.00189	CbGpPWpGaD
Pitavastatin—CYP2C9—Biological oxidations—NAT2—systemic lupus erythematosus	3.76e-05	0.00188	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—CLU—systemic lupus erythematosus	3.76e-05	0.00188	CbGpPWpGaD
Pitavastatin—ABCG2—HIF-1-alpha transcription factor network—EP300—systemic lupus erythematosus	3.71e-05	0.00185	CbGpPWpGaD
Pitavastatin—CYP2C9—Metapathway biotransformation—NAT2—systemic lupus erythematosus	3.7e-05	0.00185	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—IL10—systemic lupus erythematosus	3.7e-05	0.00185	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—CD40LG—systemic lupus erythematosus	3.7e-05	0.00185	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	3.69e-05	0.00184	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—P2RY12—systemic lupus erythematosus	3.64e-05	0.00182	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—IL4—systemic lupus erythematosus	3.6e-05	0.0018	CbGpPWpGaD
Pitavastatin—ALB—Vitamin B12 Metabolism—IFNG—systemic lupus erythematosus	3.52e-05	0.00176	CbGpPWpGaD
Pitavastatin—ABCG2—HIF-1-alpha transcription factor network—VEGFA—systemic lupus erythematosus	3.51e-05	0.00175	CbGpPWpGaD
Pitavastatin—SLCO2B1—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	3.5e-05	0.00175	CbGpPWpGaD
Pitavastatin—HMGCR—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—systemic lupus erythematosus	3.48e-05	0.00174	CbGpPWpGaD
Pitavastatin—CYP2C8—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	3.45e-05	0.00172	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—FASLG—systemic lupus erythematosus	3.44e-05	0.00172	CbGpPWpGaD
Pitavastatin—ALB—Folate Metabolism—CCL2—systemic lupus erythematosus	3.37e-05	0.00168	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	3.35e-05	0.00167	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—CSK—systemic lupus erythematosus	3.35e-05	0.00167	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—FAS—systemic lupus erythematosus	3.32e-05	0.00166	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—IL2RA—systemic lupus erythematosus	3.3e-05	0.00165	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—C3—systemic lupus erythematosus	3.27e-05	0.00163	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—NAT2—systemic lupus erythematosus	3.26e-05	0.00163	CbGpPWpGaD
Pitavastatin—ALB—Selenium Micronutrient Network—CRP—systemic lupus erythematosus	3.26e-05	0.00163	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	3.23e-05	0.00161	CbGpPWpGaD
Pitavastatin—SLCO2B1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	3.13e-05	0.00156	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—LYN—systemic lupus erythematosus	3.04e-05	0.00152	CbGpPWpGaD
Pitavastatin—ALB—Selenium Micronutrient Network—F2—systemic lupus erythematosus	3.01e-05	0.0015	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—HLA-DRB1—systemic lupus erythematosus	2.98e-05	0.00149	CbGpPWpGaD
Pitavastatin—UGT1A3—NRF2 pathway—TGFB1—systemic lupus erythematosus	2.91e-05	0.00145	CbGpPWpGaD
Pitavastatin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—systemic lupus erythematosus	2.9e-05	0.00145	CbGpPWpGaD
Pitavastatin—ALB—Folate Metabolism—IFNG—systemic lupus erythematosus	2.87e-05	0.00143	CbGpPWpGaD
Pitavastatin—CYP2C9—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	2.81e-05	0.0014	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—CD80—systemic lupus erythematosus	2.75e-05	0.00137	CbGpPWpGaD
Pitavastatin—SLCO1B3—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	2.73e-05	0.00137	CbGpPWpGaD
Pitavastatin—ALB—Selenium Micronutrient Network—CCL2—systemic lupus erythematosus	2.68e-05	0.00134	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—NAT2—systemic lupus erythematosus	2.66e-05	0.00133	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	2.59e-05	0.0013	CbGpPWpGaD
Pitavastatin—CYP2C8—Biological oxidations—RXRA—systemic lupus erythematosus	2.59e-05	0.00129	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	2.57e-05	0.00128	CbGpPWpGaD
Pitavastatin—ALB—Folate Metabolism—IL2—systemic lupus erythematosus	2.55e-05	0.00127	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—systemic lupus erythematosus	2.51e-05	0.00125	CbGpPWpGaD
Pitavastatin—UGT2B7—NRF2 pathway—TGFB1—systemic lupus erythematosus	2.48e-05	0.00124	CbGpPWpGaD
Pitavastatin—SLCO1B3—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	2.45e-05	0.00122	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—systemic lupus erythematosus	2.37e-05	0.00118	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	2.33e-05	0.00116	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—RASGRP1—systemic lupus erythematosus	2.28e-05	0.00114	CbGpPWpGaD
Pitavastatin—ALB—Vitamin B12 Metabolism—TNF—systemic lupus erythematosus	2.28e-05	0.00114	CbGpPWpGaD
Pitavastatin—ALB—Selenium Micronutrient Network—IFNG—systemic lupus erythematosus	2.28e-05	0.00114	CbGpPWpGaD
Pitavastatin—ALB—Selenium Micronutrient Network—PTGS2—systemic lupus erythematosus	2.18e-05	0.00109	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—IFNG—systemic lupus erythematosus	2.18e-05	0.00109	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—ITGAX—systemic lupus erythematosus	2.17e-05	0.00108	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—NAT2—systemic lupus erythematosus	2.17e-05	0.00108	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—F3—systemic lupus erythematosus	2.14e-05	0.00107	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	2.12e-05	0.00106	CbGpPWpGaD
Pitavastatin—CYP2C9—Biological oxidations—RXRA—systemic lupus erythematosus	2.11e-05	0.00105	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	2.07e-05	0.00103	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—NAT2—systemic lupus erythematosus	2.04e-05	0.00102	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	2.04e-05	0.00102	CbGpPWpGaD
Pitavastatin—ABCB1—HIF-1-alpha transcription factor network—EP300—systemic lupus erythematosus	2e-05	0.001	CbGpPWpGaD
Pitavastatin—ABCC2—NRF2 pathway—TGFB1—systemic lupus erythematosus	1.96e-05	0.00098	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—CLU—systemic lupus erythematosus	1.94e-05	0.000966	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—IL2—systemic lupus erythematosus	1.93e-05	0.000966	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.9e-05	0.00095	CbGpPWpGaD
Pitavastatin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—systemic lupus erythematosus	1.9e-05	0.000947	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—P2RY12—systemic lupus erythematosus	1.87e-05	0.000936	CbGpPWpGaD
Pitavastatin—ALB—Platelet degranulation—VEGFA—systemic lupus erythematosus	1.86e-05	0.000927	CbGpPWpGaD
Pitavastatin—ALB—Folate Metabolism—TNF—systemic lupus erythematosus	1.86e-05	0.000927	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—NAT2—systemic lupus erythematosus	1.84e-05	0.000921	CbGpPWpGaD
Pitavastatin—ALB—Vitamin B12 Metabolism—IL6—systemic lupus erythematosus	1.84e-05	0.000919	CbGpPWpGaD
Pitavastatin—SLCO1B1—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	1.84e-05	0.000917	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—RXRA—systemic lupus erythematosus	1.83e-05	0.000914	CbGpPWpGaD
Pitavastatin—SLCO2B1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	1.78e-05	0.000888	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—JAK1—systemic lupus erythematosus	1.77e-05	0.000884	CbGpPWpGaD
Pitavastatin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—systemic lupus erythematosus	1.77e-05	0.000883	CbGpPWpGaD
Pitavastatin—ABCC2—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	1.75e-05	0.000874	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.73e-05	0.000863	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—SELE—systemic lupus erythematosus	1.73e-05	0.000861	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—CSK—systemic lupus erythematosus	1.73e-05	0.000861	CbGpPWpGaD
Pitavastatin—ALB—Platelet degranulation—TGFB1—systemic lupus erythematosus	1.7e-05	0.000851	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	1.7e-05	0.000848	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.7e-05	0.000848	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.66e-05	0.000831	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—IL2RA—systemic lupus erythematosus	1.65e-05	0.000825	CbGpPWpGaD
Pitavastatin—SLCO1B1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	1.64e-05	0.000821	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—VEGFA—systemic lupus erythematosus	1.64e-05	0.000821	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	1.64e-05	0.000817	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.62e-05	0.000811	CbGpPWpGaD
Pitavastatin—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—systemic lupus erythematosus	1.62e-05	0.000811	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—ITGAM—systemic lupus erythematosus	1.62e-05	0.00081	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—LYN—systemic lupus erythematosus	1.57e-05	0.000783	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—SH2B3—systemic lupus erythematosus	1.54e-05	0.000768	CbGpPWpGaD
Pitavastatin—ABCG2—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	1.52e-05	0.00076	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—TGFB1—systemic lupus erythematosus	1.51e-05	0.000753	CbGpPWpGaD
Pitavastatin—ALB—Folate Metabolism—IL6—systemic lupus erythematosus	1.5e-05	0.000748	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—RXRA—systemic lupus erythematosus	1.49e-05	0.000745	CbGpPWpGaD
Pitavastatin—ALB—Selenium Micronutrient Network—TNF—systemic lupus erythematosus	1.47e-05	0.000736	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.46e-05	0.000729	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—F2—systemic lupus erythematosus	1.44e-05	0.000719	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—TNF—systemic lupus erythematosus	1.41e-05	0.000703	CbGpPWpGaD
Pitavastatin—SLCO1B3—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	1.39e-05	0.000694	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.38e-05	0.000691	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—NAT2—systemic lupus erythematosus	1.37e-05	0.000686	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.28e-05	0.000638	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—NAT2—systemic lupus erythematosus	1.27e-05	0.000635	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—RXRA—systemic lupus erythematosus	1.22e-05	0.000607	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—IFNA1—systemic lupus erythematosus	1.21e-05	0.000603	CbGpPWpGaD
Pitavastatin—ALB—Selenium Micronutrient Network—IL6—systemic lupus erythematosus	1.19e-05	0.000594	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—RASGRP1—systemic lupus erythematosus	1.18e-05	0.000587	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—PPARG—systemic lupus erythematosus	1.16e-05	0.000577	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—RXRA—systemic lupus erythematosus	1.15e-05	0.000572	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.09e-05	0.000545	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.06e-05	0.000531	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—ALB—systemic lupus erythematosus	1.04e-05	0.000519	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—RXRA—systemic lupus erythematosus	1.03e-05	0.000516	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	1.03e-05	0.000514	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—NOS3—systemic lupus erythematosus	9.94e-06	0.000496	CbGpPWpGaD
Pitavastatin—ABCC2—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	9.94e-06	0.000496	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	9.94e-06	0.000496	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	9.88e-06	0.000493	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	9.82e-06	0.00049	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	9.75e-06	0.000487	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—IL2—systemic lupus erythematosus	9.69e-06	0.000484	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—PPARG—systemic lupus erythematosus	9.42e-06	0.00047	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	9.39e-06	0.000469	CbGpPWpGaD
Pitavastatin—SLCO1B1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	9.33e-06	0.000466	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—JAK1—systemic lupus erythematosus	9.12e-06	0.000456	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—PTGS2—systemic lupus erythematosus	9.09e-06	0.000454	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	9e-06	0.000449	CbGpPWpGaD
Pitavastatin—ABCG2—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	8.64e-06	0.000432	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	8.59e-06	0.000429	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	8.56e-06	0.000428	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—IL2RA—systemic lupus erythematosus	8.52e-06	0.000425	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—ALB—systemic lupus erythematosus	8.47e-06	0.000423	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—VEGFA—systemic lupus erythematosus	8.24e-06	0.000411	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	8.23e-06	0.000411	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	8.11e-06	0.000405	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—NOS3—systemic lupus erythematosus	8.1e-06	0.000405	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	8.09e-06	0.000404	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—NAT2—systemic lupus erythematosus	7.89e-06	0.000394	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—NAT2—systemic lupus erythematosus	7.85e-06	0.000392	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—RXRA—systemic lupus erythematosus	7.7e-06	0.000384	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—PPARG—systemic lupus erythematosus	7.68e-06	0.000383	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—EP300—systemic lupus erythematosus	7.56e-06	0.000377	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—TGFB1—systemic lupus erythematosus	7.56e-06	0.000377	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	7.44e-06	0.000372	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—F2—systemic lupus erythematosus	7.42e-06	0.00037	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—PTGS2—systemic lupus erythematosus	7.41e-06	0.00037	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PPARG—systemic lupus erythematosus	7.24e-06	0.000361	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	7.14e-06	0.000357	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—RXRA—systemic lupus erythematosus	7.13e-06	0.000356	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	6.95e-06	0.000347	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—ALB—systemic lupus erythematosus	6.91e-06	0.000345	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—NAT2—systemic lupus erythematosus	6.88e-06	0.000343	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—NOS3—systemic lupus erythematosus	6.6e-06	0.00033	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PPARG—systemic lupus erythematosus	6.53e-06	0.000326	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—ALB—systemic lupus erythematosus	6.51e-06	0.000325	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—NAT2—systemic lupus erythematosus	6.42e-06	0.000321	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	6.27e-06	0.000313	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	6.24e-06	0.000311	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—NOS3—systemic lupus erythematosus	6.22e-06	0.000311	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—EP300—systemic lupus erythematosus	6.16e-06	0.000308	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—PTGS2—systemic lupus erythematosus	6.04e-06	0.000302	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—NOS3—systemic lupus erythematosus	5.89e-06	0.000294	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—ALB—systemic lupus erythematosus	5.87e-06	0.000293	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PTGS2—systemic lupus erythematosus	5.69e-06	0.000284	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	5.64e-06	0.000282	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—NOS3—systemic lupus erythematosus	5.62e-06	0.00028	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PTGS2—systemic lupus erythematosus	5.14e-06	0.000256	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	5.11e-06	0.000255	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—EP300—systemic lupus erythematosus	5.02e-06	0.000251	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—IL2—systemic lupus erythematosus	5e-06	0.000249	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	4.94e-06	0.000246	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	4.91e-06	0.000245	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PPARG—systemic lupus erythematosus	4.86e-06	0.000243	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—EP300—systemic lupus erythematosus	4.73e-06	0.000236	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	4.67e-06	0.000233	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	4.59e-06	0.000229	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PPARG—systemic lupus erythematosus	4.5e-06	0.000225	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—EP300—systemic lupus erythematosus	4.48e-06	0.000224	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—RXRA—systemic lupus erythematosus	4.42e-06	0.000221	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—RXRA—systemic lupus erythematosus	4.4e-06	0.00022	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—ALB—systemic lupus erythematosus	4.37e-06	0.000218	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—EP300—systemic lupus erythematosus	4.27e-06	0.000213	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—VEGFA—systemic lupus erythematosus	4.25e-06	0.000212	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—NOS3—systemic lupus erythematosus	4.18e-06	0.000209	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	4.1e-06	0.000205	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	4.08e-06	0.000204	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—ALB—systemic lupus erythematosus	4.05e-06	0.000202	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	4.02e-06	0.000201	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—TGFB1—systemic lupus erythematosus	3.9e-06	0.000195	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—NOS3—systemic lupus erythematosus	3.87e-06	0.000193	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—RXRA—systemic lupus erythematosus	3.86e-06	0.000192	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PTGS2—systemic lupus erythematosus	3.82e-06	0.000191	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—RXRA—systemic lupus erythematosus	3.6e-06	0.00018	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PTGS2—systemic lupus erythematosus	3.54e-06	0.000177	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	3.34e-06	0.000167	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—EP300—systemic lupus erythematosus	3.18e-06	0.000159	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—EP300—systemic lupus erythematosus	2.95e-06	0.000147	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PPARG—systemic lupus erythematosus	2.79e-06	0.000139	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PPARG—systemic lupus erythematosus	2.78e-06	0.000139	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—ALB—systemic lupus erythematosus	2.51e-06	0.000125	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PPARG—systemic lupus erythematosus	2.43e-06	0.000122	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—NOS3—systemic lupus erythematosus	2.4e-06	0.00012	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—NOS3—systemic lupus erythematosus	2.39e-06	0.000119	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PPARG—systemic lupus erythematosus	2.27e-06	0.000114	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PTGS2—systemic lupus erythematosus	2.2e-06	0.00011	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—ALB—systemic lupus erythematosus	2.19e-06	0.000109	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PTGS2—systemic lupus erythematosus	2.19e-06	0.000109	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—NOS3—systemic lupus erythematosus	2.09e-06	0.000105	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ALB—systemic lupus erythematosus	2.04e-06	0.000102	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—NOS3—systemic lupus erythematosus	1.96e-06	9.76e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PTGS2—systemic lupus erythematosus	1.91e-06	9.56e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—EP300—systemic lupus erythematosus	1.83e-06	9.13e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—EP300—systemic lupus erythematosus	1.82e-06	9.07e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PTGS2—systemic lupus erythematosus	1.79e-06	8.93e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—EP300—systemic lupus erythematosus	1.59e-06	7.95e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—EP300—systemic lupus erythematosus	1.49e-06	7.43e-05	CbGpPWpGaD
